全文获取类型
收费全文 | 836篇 |
免费 | 45篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 75篇 |
妇产科学 | 4篇 |
基础医学 | 84篇 |
口腔科学 | 28篇 |
临床医学 | 106篇 |
内科学 | 204篇 |
皮肤病学 | 23篇 |
神经病学 | 25篇 |
特种医学 | 184篇 |
外科学 | 40篇 |
综合类 | 24篇 |
预防医学 | 38篇 |
眼科学 | 16篇 |
药学 | 35篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2024年 | 1篇 |
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 10篇 |
2020年 | 4篇 |
2019年 | 12篇 |
2018年 | 18篇 |
2017年 | 17篇 |
2016年 | 10篇 |
2015年 | 20篇 |
2014年 | 13篇 |
2013年 | 29篇 |
2012年 | 20篇 |
2011年 | 12篇 |
2010年 | 47篇 |
2009年 | 38篇 |
2008年 | 15篇 |
2007年 | 26篇 |
2006年 | 18篇 |
2005年 | 38篇 |
2004年 | 15篇 |
2003年 | 7篇 |
2002年 | 12篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 22篇 |
1998年 | 47篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 34篇 |
1994年 | 41篇 |
1993年 | 35篇 |
1992年 | 12篇 |
1991年 | 19篇 |
1990年 | 9篇 |
1989年 | 23篇 |
1988年 | 46篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 29篇 |
1984年 | 7篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1976年 | 12篇 |
1975年 | 3篇 |
排序方式: 共有922条查询结果,搜索用时 62 毫秒
31.
32.
33.
34.
35.
Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA‐UC study 下载免费PDF全文
36.
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease 总被引:5,自引:0,他引:5
Mannucci PM; Lattuada A; Castaman G; Lombardi R; Colibretti ML; Ciavarella N; Rodeghiero F 《Blood》1989,74(7):2433-2436
To characterize the heterogeneity of severe (type III) von Willebrand disease (vWD), plasma and platelet von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor activity (Ricof) were measured in 28 obligatory heterozygotes (ie, parents or children of probands from 15 different kindreds with severe vWD). On the average, heterozygotes had low levels of vWF in both platelets and plasma. There was, however, considerable heterogeneity, with four distinct patterns. Eleven heterozygotes had concordant reduction of vWF:Ag and Ricof in both plasma and platelets; five had low levels of vWF:Ag and Ricof in plasma contrasting with normal levels in platelets; eight had a peculiar pattern, the reverse of the above (ie, low levels in platelets and normal levels in plasma); and in one, both vWF measurements were normal in plasma and platelets. These patterns were genetically determined: they were consistent in four couples of consanguineous heterozygotes and in two couples carrying the same gene deletion. Only the remaining three heterozygotes had no clearly identifiable pattern. Other findings of this study were that although most of the heterozygotes had normal bleeding times, the 7 of 28 who had prolonged bleeding times had concordantly low levels of vWF measurements in both plasma and platelets. In conclusion, this large series of obligatory heterozygotes provides evidence for phenotypic and genotypic heterogeneity of severe vWD. 相似文献
37.
Sabino Riestra Carlos Taxonera Yamile Zabana Daniel Carpio Belén Beltrán Míriam Mañosa Ana Gutiérrez Manuel Barreiro-de Acosta 《Gastroenterologia y hepatologia》2021,44(1):51-66
There is evidence that following the recommendations on screening and treatment of tuberculosis infection does not completely prevent the onset of tuberculosis in patients with inflammatory bowel disease. This fact, and the increasing use of new biologics and immunomodulators, has led the Spanish Group Working on Crohn's Disease and Ulcerative Colitis to update their recommendations for the prevention of tuberculosis in patients with inflammatory bowel disease. Diagnostic methods for latent tuberculosis infection, different scenarios in which screening is to be performed, strategies to reduce the risk of tuberculosis once biological treatment is initiated and chemoprophylaxis guidelines for latent tuberculosis infection are reviewed, as well as the management of active tuberculosis during biological treatment. Finally, there is a summary of the current recommendations within the paper and in an algorithm. 相似文献
38.
Paul T Kr ner Megan ML Engels Benjamin S Glicksberg Kipp W Johnson Obaie Mzaik Jeanin E van Hooft Michael B Wallace Hashem B El-Serag Chayakrit Krittanawong 《World journal of gastroenterology : WJG》2021,27(40):6794-6824
The development of artificial intelligence (AI) has increased dramatically in the last 20 years, with clinical applications progressively being explored for most of the medical specialties. The field of gastroenterology and hepatology, substantially reliant on vast amounts of imaging studies, is not an exception. The clinical applications of AI systems in this field include the identification of premalignant or malignant lesions (e.g., identification of dysplasia or esophageal adenocarcinoma in Barrett’s esophagus, pancreatic malignancies), detection of lesions (e.g., polyp identification and classification, small-bowel bleeding lesion on capsule endoscopy, pancreatic cystic lesions), development of objective scoring systems for risk stratification, predicting disease prognosis or treatment response [e.g., determining survival in patients post-resection of hepatocellular carcinoma), determining which patients with inflammatory bowel disease (IBD) will benefit from biologic therapy], or evaluation of metrics such as bowel preparation score or quality of endoscopic examination. The objective of this comprehensive review is to analyze the available AI-related studies pertaining to the entirety of the gastrointestinal tract, including the upper, middle and lower tracts; IBD; the hepatobiliary system; and the pancreas, discussing the findings and clinical applications, as well as outlining the current limitations and future directions in this field. 相似文献
39.
Summary
d-penicillamine (d-pen) inhibited pokeweed mitogen-induced plaque-forming cell (PFC) response in a dose-dependent manner. This inhibition was irreversible as preincubation for a few hours with the drug followed by washes still caused suppression of the PFC response. Pretreatment of the different mononuclear cell populations with d-pen for short periods (2–24 h) showed that both macrophages (Mo) and B lymphocytes were affected by the drug. By contrast T cells were resistant. Mo appears to be more susceptible to d-pen than B cells, and in the case of drug-treated Mo, the response was restored completely with the addition of 20% fresh Mo. Our results show that d-pen, without exogenous Cu2+, inhibits the polyclonal immunoglobulin secretion by human mononuclear cells in vitro due to a strong effect on both Mo and B cells. This may explain the decrease in serum immunoglobulin levels seen in patients with rheumatoid arthritis undergoing this therapy. 相似文献
40.